Literature DB >> 17917059

Roles of TRAF6 in CD40 signaling.

Bruce S Hostager1.   

Abstract

CD40 provides signals crucial to the activation of antigen-presenting cells during humoral and cell-mediated immune responses. A complex cohort of proteins interacts with the cytoplasmic domain of CD40 and mediates signaling. One member of this cohort is TNF receptor associated factor six (TRAF6). TRAF6 contributes to the CD40-mediated activation of NF-kappaB, stress-activated protein kinases, and perhaps other signaling molecules. TRAF6 may have roles as an adapter molecule, an activator of mitogen-activated protein kinases, and as a repressor of certain signaling circuits. Establishing the significance and interplay of these roles will lead to a more complete understanding of mechanisms important to the CD40-mediated activation of the immune system and will reveal novel targets for the development of therapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17917059     DOI: 10.1007/s12026-007-0082-3

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  65 in total

1.  Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1).

Authors:  K D Brown; B S Hostager; G A Bishop
Journal:  J Exp Med       Date:  2001-04-16       Impact factor: 14.307

2.  Characterization of the roles of TNF receptor-associated factor 6 in CD40-mediated B lymphocyte effector functions.

Authors:  S V Jalukar; B S Hostager; G A Bishop
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

3.  Regulation of TRAF2 signaling by self-induced degradation.

Authors:  Kevin D Brown; Bruce S Hostager; Gail A Bishop
Journal:  J Biol Chem       Date:  2002-03-21       Impact factor: 5.157

4.  Cooperation between TNF receptor-associated factors 1 and 2 in CD40 signaling.

Authors:  Ping Xie; Bruce S Hostager; Melissa E Munroe; Carissa R Moore; Gail A Bishop
Journal:  J Immunol       Date:  2006-05-01       Impact factor: 5.422

5.  The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated immunoglobulin class switching.

Authors:  Haifa Jabara; Dhafer Laouini; Erdyni Tsitsikov; Emiko Mizoguchi; Atul Bhan; Emanuela Castigli; Fatma Dedeoglu; Vadim Pivniouk; Scott Brodeur; Raif Geha
Journal:  Immunity       Date:  2002-09       Impact factor: 31.745

6.  TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src.

Authors:  B R Wong; D Besser; N Kim; J R Arron; M Vologodskaia; H Hanafusa; Y Choi
Journal:  Mol Cell       Date:  1999-12       Impact factor: 17.970

Review 7.  Immune regulation by CD40 and its ligand GP39.

Authors:  T M Foy; A Aruffo; J Bajorath; J E Buhlmann; R J Noelle
Journal:  Annu Rev Immunol       Date:  1996       Impact factor: 28.527

8.  A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes.

Authors:  F K Chan; M J Lenardo
Journal:  Eur J Immunol       Date:  2000-02       Impact factor: 5.532

9.  Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation.

Authors:  Betty Lamothe; Arnaud Besse; Alejandro D Campos; William K Webster; Hao Wu; Bryant G Darnay
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

10.  Molecular basis for CD40 signaling mediated by TRAF3.

Authors:  C Z Ni; K Welsh; E Leo; C K Chiou; H Wu; J C Reed; K R Ely
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

View more
  18 in total

Review 1.  Immunology at the University of Iowa.

Authors:  Gail A Bishop
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

2.  CD40/TRAF6 switch in neointimal hyperplasia.

Authors:  Nikolay Malinin; Tatiana Byzova
Journal:  Blood       Date:  2008-05-01       Impact factor: 22.113

Review 3.  Lipid rafts in immune signalling: current progress and future perspective.

Authors:  Pallavi Varshney; Vikas Yadav; Neeru Saini
Journal:  Immunology       Date:  2016-07-11       Impact factor: 7.397

4.  Identification of functionally distinct TRAF proinflammatory and phosphatidylinositol 3-kinase/mitogen-activated protein kinase/extracellular signal-regulated kinase kinase (PI3K/MEK) transforming activities emanating from RET/PTC fusion oncoprotein.

Authors:  Josephine H F Wixted; Jay L Rothstein; Laurence C Eisenlohr
Journal:  J Biol Chem       Date:  2011-12-09       Impact factor: 5.157

Review 5.  Strategies for the identification of ubiquitin ligase inhibitors.

Authors:  Seth J Goldenberg; Jeffrey G Marblestone; Michael R Mattern; Benjamin Nicholson
Journal:  Biochem Soc Trans       Date:  2010-02       Impact factor: 5.407

6.  TNF receptor-associated factor 5 is required for optimal T cell expansion and survival in response to infection.

Authors:  Zachary J Kraus; Jodie S Haring; Gail A Bishop
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

7.  Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1.

Authors:  Catherine J Hwang; Nikoo Afifiyan; Daniel Sand; Vibha Naik; Jonathan Said; Stephen J Pollock; Beiling Chen; Richard P Phipps; Robert A Goldberg; Terry J Smith; Raymond S Douglas
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-12-30       Impact factor: 4.799

8.  Otubain 2 is a novel promoter of beta cell survival as revealed by siRNA high-throughput screens of human pancreatic islets.

Authors:  A Beck; Y Vinik; H Shatz-Azoulay; R Isaac; S Streim; G Jona; S Boura-Halfon; Y Zick
Journal:  Diabetologia       Date:  2013-03-21       Impact factor: 10.122

9.  Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile.

Authors:  Esther Lutgens; Dirk Lievens; Linda Beckers; Erwin Wijnands; Oliver Soehnlein; Alma Zernecke; Tom Seijkens; David Engel; Jack Cleutjens; Anna M Keller; Shalin H Naik; Louis Boon; Hafid Ait Oufella; Ziad Mallat; Cory L Ahonen; Randolph J Noelle; Menno P de Winther; Mat J Daemen; Erik A Biessen; Christian Weber
Journal:  J Exp Med       Date:  2010-01-25       Impact factor: 14.307

10.  Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes.

Authors:  Wen Zhang; Qun Shi; Xiaotian Xu; Hua Chen; Wei Lin; Fengchun Zhang; Xiaofeng Zeng; Xuan Zhang; Denian Ba; Wei He
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.